OP04 - Recombinant Histone Deacetylase 6 (rHDAC6) treatment protects against influenza A virus (IAV) infection and disease in vivo - LSC 2023 - Post-viral lung diseases - from basic immunology to clinical phenotypes and therapy

Lung Science Conference 2023

At the forefront of basic and translational respiratory science, this conference is an essential event for budding respiratory researchers looking to boost their career.

Educational aims

- To present the very best of international lung science research
- To highlight new discoveries likely to impact on the future of respiratory medicine
- To encourage debate and interaction between young postdoctoral scientists and established investigators

Session 2: Host-immune response to virus infections of the lung (part 2)

Chair(s): Niki Ubags, Raquel Guillamat Prats

Session type: Session

OP04 - Recombinant Histone Deacetylase 6 (rHDAC6) treatment protects against influenza A virus (IAV) infection and disease in vivo

Katie Daly

EVENTS HOME

Previous presentation

Next presentation

Session content

OP04 Recombinant Histone Deacetylase 6 (rHDAC6) treatment protects against influenza A virus (IAV) infection and disease in vivo

Katie Daly

Replay

Poster

Abstract

Slides

Adaptive immune responses in virus infections

Hermelijn H. Smits

Replay

Slides

OP05 Elevated CD27-IgD- B cells in Post-Acute COVID-19 Sequalae Patients with Rheumatological Symptoms

Nadia Suray Tan

Replay

Poster

Abstract

Slides

Dendritic cell subsets in respiratory virus infection

Hamida Hammad

Replay

Slides

OP06 Biomarker identification in fatal and post-acute sequelae of SARS-CoV-2 (PASC) lungs leads to epigenetic targeting in PASC-related fibrosis

Milena Espindola

Replay

Poster

Abstract

Slides

CDN Connection Issue

Lung Science Conference 2023

#{title}